Isolated heart models for studying cardiac electrophysiology: a historical perspective and recent advances by Kung, J et al.
Title Isolated heart models for studying cardiac electrophysiology: ahistorical perspective and recent advances
Author(s) Yeo, JM; Tse, V; Kung, J; Lin, HY; Lee, YT; Kwan, SKJ; Yan, BP;Tse, G
Citation Journal of Basic and Clinical Physiology and Pharmacology,2017, v. 28 n. 3, p. 191-200
Issued Date 2017
URL http://hdl.handle.net/10722/238673
Rights
The final publication is available at www.degruyter.com; This
work is licensed under a Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License.
J Basic Clin Physiol Pharmacol 2017; 28(3): 191–200
Review
Jie Ming Yeo, Vivian Tse, Judy Kung, Hiu Yu Lin, Yee Ting Lee, Joseph Kwan, Bryan P. Yan  
and Gary Tse*
Isolated heart models for studying cardiac 
electrophysiology: a historical perspective and 
recent advances
DOI 10.1515/jbcpp-2016-0110
Received July 18, 2016; accepted October 12, 2016; previously 
published online January 7, 2017
Abstract: Experimental models used in cardiovascular 
research range from cellular to whole heart preparations. 
Isolated whole hearts show higher levels of structural 
and functional integration than lower level models such 
as tissues or cellular fragments. Cardiovascular diseases 
are multi-factorial problems that are dependent on highly 
organized structures rather than on molecular or cellular 
components alone. This article first provides a general 
introduction on the animal models of cardiovascular dis-
eases. It is followed by a detailed overview and a historical 
perspective of the different isolated heart systems with a 
particular focus on the Langendorff perfusion method for 
the study of cardiac arrhythmias. The choice of species, per-
fusion method, and perfusate composition are discussed in 
further detail with particular considerations of the theoreti-
cal and practical aspects of experimental settings.
Keywords: animal models; cardiac electrophysiology; 
Langendorff mode; perfusate composition; perfusion 
methods; species differences; working mode.
Introduction
Animals have been used to study diseases affecting 
humans. However, there is a general compromise between 
clinical relevance and experimental utility when using 
animal models [1]. The advantages are that the further one 
moves away from using human tissues, usually the quality, 
quantity and reproducibility of the data are greater, and 
the cost incurred are lower. However, these may be offset 
by the model bearing less relevance to the human condi-
tion concerned. Therefore, experimental designs must 
balance these conflicting factors. Experimental models 
used in cardiovascular research range from cellular to 
whole heart preparations. Isolated whole hearts show 
higher levels of structural and functional integration than 
lower level models such as tissues or cellular fragments. 
Cardiovascular diseases are multi-factorial problems that 
are dependent on highly organized structures rather than 
on molecular or cellular components alone [2]. The use of 
intact hearts in the study of cardiac arrhythmias, there-
fore, has the advantage of being physiologically more 
relevant. There are many variations in the design of these 
whole heart models, including the choice of species, per-
fusion method, and perfusate composition. These factors 
are discussed in turn.
Species
Many animal species have been used for cardiovascu-
lar research. They can be divided into two groups, small 
animals such as the mouse, rat, guinea pig and rabbit, 
and large animals such as the dog, pig, and sheep [3–8]. 
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An important factor in deciding which model to use is cost. 
Despite the increasing amount of funding invested in bio-
medical research [9], there are often financial constraints 
at the levels of individual research groups, institutions 
and commercial corporations [10], meaning that resources 
need to be used efficiently and responsibly. As a result, 
small animals are more commonly selected because they 
consume less food and occupy less space, and are thus 
cheaper to maintain than large animals. However, other 
factors such as the experimental conditions required also 
determine the choice of the species. For example, experi-
mental studies in mice have accelerated our understand-
ing of the pathophysiology of cardiovascular diseases [11]. 
Mice grow and reproduce rapidly, which allow greater 
number of experiments to be conducted within a defined 
period of time. Although they show important differences 
to humans in terms of their physiology, their amenability 
to genetic manipulation means that they are very useful 
for studying the consequences of single mutations in 
cardiac arrhythmias [12–15]. Mice have also been used to 
study macrovascular complications of cardio-metabolic 
disorders such as hypertension and diabetes mellitus [16, 
17], demonstrating the critical role endothelial dysfunc-
tion plays in their disease pathogenesis. Identification 
of the molecular events is crucial for the development of 
future therapy to improve endothelial dysfunction, which 
could potentially slow down or even reverse the progres-
sion of these conditions [18–22]. It is because of these 
reasons that mice are almost used ubiquitously in bio-
medical research institutions.
However, the use of mice for studying cardiac elec-
trophysiology is not without limitations. Firstly, mouse 
hearts are electrically more stable than human hearts 
because of their small sizes. Spontaneous ventricular 
arrhythmias are, therefore, less likely to occur [23]. Sec-
ondly, arrhythmias are easier to reverse in mice than in 
larger species, making them invaluable for the evaluation 
of the effectiveness of anti-arrhythmic drugs, but efficacy 
could be overestimated. There are also other important 
differences between mouse and human cardiac elec-
trophysiology. For example, the resting heart rate in the 
mouse is around 600 beats per minute, whereas that of 
humans is 60 beats per minute [24]. The shapes of cardiac 
action potentials also differ between these species, due to 
differing repolarizing currents. In mice, action potentials 
have shorter durations and do not have a plateau phase 
[25] that is observed in larger species such as humans. The 
explanation is that Ito is the major repolarizing current 
whereas IKr and IKs have a lesser role in mice [26]. By con-
trast, IKr and IKs play predominant roles in ventricular 
repolarization of human hearts [27]. Moreover, calcium 
handling in cardiomyocytes in mice is different. Calcium 
reuptake almost exclusively involves sarcoplasmic reticu-
lum Ca2+-ATPase with little contribution from the Na+-Ca2+ 
exchanger (NCX) [28, 29]. By contrast, NCX plays a greater 
role in humans and exploration of its contributions to 
arrhythmogenesis, therefore, requires the use of species 
other than mice. The use of other popular species such as 
rabbits [30–37] and guinea pigs [35, 38–45] has provided 
much insights into the mechanisms of arrhythmic disor-
ders. Although guinea pigs lack Ito, they possess rectifier 
currents that make the particularly suitable for repolariza-
tion disorders such as long QT syndromes [46–49].
By contrast, larger animals have better approxima-
tions in terms of heart size and musculature, and, there-
fore, have closer hemodynamic parameters, such as 
coronary blood flow and cardiac output, to humans than 
smaller animals [50–53]. As a result, sheep hearts have 
been used as a model system for testing of prosthetic heart 
valves [54–56]. Dog and rabbit hearts have ionic currents 
that correspond to those found in human hearts, with 
similar morphology and duration of the cardiac action 
potential observed [30–33, 57, 58]. They are, therefore, 
useful for investigating electrophysiological mechanisms 
underlying cardiac arrhythmias and the experimental 
data obtained from them bear greater clinical relevance 
to the human conditions. However, disadvantages are that 
large volumes of fluid for perfusion are needed and the 
experimental apparatus are large and cumbersome when 
compared to experiments conducted in smaller animal 
species such as rats and mice [59–63].
Perfusion method
Elias Cyon was among the first investigators to devise the 
isolated frog heart model [64]. The frog is distinct from 
mammals in that it is a cold-blooded species. Its heart has 
only three chambers, with two atria and a single ventri-
cle, rather than the four chambers, with two atria and two 
ventricles, found in mammalian hearts. The frog heart has 
no coronary circulatory system and the exchange of gases 
and metabolites takes place by diffusion. In the perfusion 
setup by Cyon, the cannula is inserted into the vena cava. 
A pump is then used to deliver serum obtained from rabbit 
blood through the cannula and into the vena cava. The 
serum is then ejected via into the aorta, through a glass 
tube and back to the vena cava. The circulatory system is 
surrounded by a glass cylinder that is filled with fluid. The 
temperature of the heart preparations can be kept con-
stant or altered using this fluid.
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Langendorff heart
Based on Cyon’s frog heart model, the isolated perfused 
mammalian heart model was established in 1897 by 
Oscar Langendorff [65], after whom the perfusion method 
is named [66]. In the original experiments performed by 
Langendorff, hearts from cats, dogs, and rabbits were 
used. In his setup, a cannula is inserted and fixed in 
the ascending aorta to allow the delivery of blood into 
the heart in a retrograde manner. This causes the aortic 
valve to shut, and thus the perfusate is unable to fill the 
left ventricle. Instead, it enters the coronary arteries via 
the ostia, passes through the coronary circulation, and 
drains into the right atrium via the coronary sinus. Once 
perfusion starts, the heart is resuscitated, after which it 
regains its normal automaticity and can continue to beat 
spontaneously for several hours. This discovery led Lan-
gendorff to conclude that the heart receives oxygen and 
nutrients from the coronary arteries because their per-
fusion is sufficient to induce the normal heart beat. His 
other contributions led to the demonstrations of many 
important physiological findings [65, 67], which include 
the following: (1) introduction of potassium chloride to 
the heart is sufficient to cause cardiac arrest; (2) mus-
carine exerts negative chronotropic and inotropic effects 
on the heart, eventually causing diastolic arrest, and 
that atropine exerts effects opposite to muscarine; (3) 
increased and decreased temperatures resulted in sinus 
tachycardia and bradycardia, respectively; and (4) liga-
tion of coronary arteries led to cardiac failure and sub-
sequent arrest.
In Langendorff’s experimental system, the perfusate 
was delivered at a constant hydrostatic pressure. This 
was achieved by keeping the level of the reservoir con-
stant. He was able to estimate coronary flow based on 
volumetric determination of the coronary effluent that 
emerged from the right atrium over time. However, coro-
nary flow measurements using this method had several 
limitations, as pointed out previously [68]. Firstly, they 
were not accurate, as outflow from the heart could take 
place without the perfusate having first passed through 
the coronary circulation because of aortic valve incom-
petence [69]. Secondly, they were not instantaneous 
because there was a lag between changes in the coronary 
vessels and the arrival of the perfusate at the recorder 
[70]. Finally, they were not always continuous, and so 
could not detect transient changes in flow rate. Nowa-
days, the flow rate can be determined more accurately by 
using a flow meter.
Katz subsequently modified Langendorff’s con-
stant pressure method, developing a system that instead 
delivered the perfusate at a constant flow rate [71]. This 
was achieved by the addition of a peristaltic roller pump 
between the reservoir and the heart. In this setup, a pres-
sure transducer is used to measure the changes in coronary 
pressure as an index of vessel resistance. An advantage 
of this method is that the pressure transducer was more 
sensitive, making it possible to monitor coronary flow 
continuously and instantaneously [72]. An example of 
an electrophysiology rig in Langendorff perfusion mode 
using a constant flow rate is shown in Figure  1. Using 
this setup, the electrophysiological mechanisms underly-
ing arrhythmogenesis in different disease models can be 
examined using different pacing protocols. For example, 
an increase in the incidence of triggered activity was 
observed during regular pacing under hypokalemic con-
ditions (Figure 2, left). Moreover, ventricular arrhythmias 
were induced during S1S2 pacing (Figure 2, right), where 
action potential duration (APD) alternans, which arise 
under conditions of steep APD restitution, were thought 
to increase the likelihood of reentry (Figure 3). The reader 
is directed to this article here for the mechanisms that 
generate triggered (Figure 4) and reentrant (Figure 5) 
arrhythmogenesis [75].
The decision as to which system to use depends on 
the precise experimental requirements. For example, per-
fusion at a constant flow rate overrides the autoregulatory 
mechanisms of the coronary vessels. Therefore, they do 
not automatically alter the amount of perfusate delivered 
to the whole heart when there is increased work, perhaps 
caused by an increased heart rate from more rapid pacing, 
or administration of inotropic agents or other drugs [70]. 
This can lead to ischemia when the perfusion cannot 
match the increased metabolic demands of the working 
myocardium [76]. Arguably, it is more physiological to 
Figure 1: An experimental rig used for examining electrophysiologi-
cal properties in mouse hearts using the Langendorff perfusion 
method at a constant flow rate.
The Figure has been reproduced from Choy et al. (2016) with 
 permission [73].
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use a constant pressure setup because intact autoregula-
tory mechanisms permit perfusion matching with tissue 
demand [77]. However, there are potential problems in 
using a constant pressure setup in arrhythmogenicity 
studies. Normally in a regular rhythm, the ventricular 
pressure exceeds the perfusion pressure during systole. 
By contrast, during ventricular tachy-arrhythmias, ven-
tricular pressure will drop below the perfusion pressure. 
The occurrence of these arrhythmias would lead to a vari-
able contractile state, which can have an adverse influ-
ence on global and regional perfusion in the constant 
pressure mode, leading to confounding factors such as 
ischemia.
Ejecting heart
Other perfusion modes in addition to the Langendorff 
method have also been devised. The ejecting heart prep-
aration pioneered by Neely and Morgan in rats [78, 79], 
also known as the working heart, was capable of per-
forming physiologically relevant, mechanical work. In 
this system, the aorta was attached to an aortic outflow 
line whereas the left atrium was connected to the atrial 
inflow line. The latter delivered perfusate at a constant 
hydrostatic pressure to the left atrium (preload). As the 
left ventricle contracted and relaxed, the perfusate left 
the aortic outflow line against a constant hydrostatic 
pressure (afterload). The advantage of this system is that 
delivery of the perfusate to the working myocardium is 
Dynamic pacing
Control (small APD alternans)
Restitution curves
Control (normal APD restitution)
Hypokalaemia (steep APD restitution)Hypokalaemia (exacerbated APD alternans)
M
AP
 (V
)
M
AP
 (V
)
50
60
50
40
30
20
10
0
5
4
3
2
1
0
40
30
20
10
0
0 50 100
Diastolic interval (ms)
150
0 50 100
Diastolic interval (ms)
150
2
1
0
G
ra
di
en
t
G
ra
di
en
t
AP
D
90
 
(m
s)
AP
D
90
 
(m
s)
Figure 3: Hypokalaemia exacerbates APD alternans at fast heart rates (left) due to steep APD restitution (right).
The Figure has been reproduced from Choy et al. (2016) with permission [73]. Original traces have been reproduced from Tse et al. (2016) [74] 
with permission.
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Figure 2: An example of a disease model for studying the mecha-
nisms of cardiac arrhythmias.
Hypokalaemia prolongs APDs, which predisposes to triggered activ-
ity (left). This AP prolongation and reduced refractoriness together 
form a re-entrant substrate. The use of programmed electrical 
stimulation can reliably provoke ventricular arrhythmias (right). The 
Figure has been reproduced from Choy et al. (2016) with permission 
[73]. Original traces have been reproduced from Tse et al. (2016) [74] 
with permission.
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more physiological, involving orthograde perfusion of 
coronary arteries rather than retrograde perfusion in the 
Langendorff mode.
Other isolated heart models
The right-side working mode combines retrograde flow of 
the Langendorff perfusion through the aorta with ante-
grade flow through the right atrium and ventricle [80]. 
In the four-chamber working mode, the perfusate is cir-
culated through the heart in a physiological manner, as 
two pumps provide input flows into the right and left atria 
simultaneously [81]. This differs from the Langendorff per-
fusion method in many respects [80]. Firstly, it involves 
two-way flow through the aorta, whereas the Langendorff 
perfusion method allows only retrograde flow. Secondly, 
it results in all four cardiac chambers being filled with 
changing volumes, preserving the natural flow through 
the heart. Thirdly, in this mode the aortic valve opens and 
closes as the heart contracts and relaxes, whereas in the 
Langendorff mode the aortic valve is kept shut by the ret-
rograde perfusion. Finally, in this mode the coronary flow 
is determined by the heart itself, whereas in the Langen-
dorff mode it is determined by the rate set by the peristal-
tic roller pump.
Insights into cardiac electrophysiology 
from the use of isolated hearts
There are advantages of using isolated hearts as the 
primary experimental system. Firstly, they allow the 
investigation of changes in cardiac parameters inde-
pendent of systemic influences [82], including those of 
the central [83] and autonomic [84, 85] nervous systems 
(ANS) [86]. For example, denervation of the heart removes 
the confounding effects of the ANS, which is important 
because sympathetic and vagal stimulation exerts an 
important source of influence on arrhythmogenesis [87]. 
If one wishes to investigate the contributions of the ANS, 
then sympathomimetic or parasympathomimetic agents 
can simply be added to the perfusate solutions [88]. It 
was originally assumed that the use of such agents would 
simulate the endogenous effects of autonomic input into 
the heart. However, it was found that their effects differed 
from those obtained by stimulation of intact autonomic 
nerves, as eloquently demonstrated by Ng’s group [89]. Ng 
and colleagues elegantly designed a modified version of 
the Langendorff preparation with intact dual autonomic 
innervation using rabbit hearts [90]. Since then, this 
model has been extensively used to explore the effects of 
direct stimulation of sympathetic and parasympathetic 
nerves on cardiac physiology, such as heart rate [91], Ca2+ 
handling and contractile force development [92, 93], elec-
trical restitution and alternans [94–96] and arrhythmo-
genesis [97, 98].
Secondly, the isolated intact heart is more physiologi-
cal than lower levels of organizational structures such as 
tissues and cells. Indeed, the Langendorff heart model 
has been an valuable tool for drug cardiotoxicity screen-
ing [99] and for exploration of the roles of conduction or 
repolarization abnormalities in cardiac arrhythmogen-
esis in different disease models [100–103]. For example, 
the arrhythmogenic effects of doxorubin-induced heart 
failure were examined under different loading conditions 
[104]. A low incidence of arrhythmias was observed during 
unloading (Langendorff mode). Imposition of a higher 
preload (in the working mode) produced greater arrhyth-
mia inducibility that was associated with shortening of 
both APDs and effective refractory periods. Moreover, 
experiments conducted in mouse hearts have shed light 
into distinct roles of triggered activity and reentry, and 
the electrophysiological mechanisms responsible for their 
Figure 4: Triggered activity can arise from early or delayed afterde-
polarizations, respectively.
The Figure has been adapted from Tse et al. (2016) with 
 permission [75].
Figure 5: Circus-type re-entry can involve an anatomical (left) or 
functional (right) obstacle, around which the action potential wave 
can travel.
The Figure has been adapted from Tse et al. (2016) with 
 permission [75].
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generation [73]. The use of isolated heart systems in pre-
clinical studies have provided much insights for transla-
tional application, such as the development of novel risk 
markers for stratifying arrhythmic risk in human popula-
tions [105–110].
To enhance the validity of experimental data arising 
from pre-clinical research, the Lambeth Conventions II 
was held in 2010, which led to the development of guide-
lines on experimental design, choice of animal species to 
model human conditions, and the methodology used to 
induce disease processes, as well as definitions of differ-
ent types of arrhythmias [111].
Perfusate composition
The different types of perfusates can be divided into crys-
talloid, colloid and cell based solutions, which will be 
discussed in turn. The most commonly used perfusate for 
maintaining cardiac viability is based on the crystalloid 
buffer solution described by Krebs and Henseleit in 1932 
[112]. It has the following composition with the respective 
concentrations indicated in brackets: NaCl (118.5  mM), 
NaHCO3 (25.0 mM), KCl (4.7 mM), MgSO4 (1.2 mM), KH2PO4 
(1.2 mM), glucose (11 mM), and CaCl2 (2.5 mM). The com-
position of the Krebs-Henseleit buffer solution is meant 
to mimic that of plasma in the blood. However, this origi-
nal formulation did not take into account the binding of 
calcium to plasma proteins, with the consequence that 
its calcium content at 2.5  mM was approximately twice 
the amount of the ionized calcium normally present 
in plasma. Since then, investigators have used lower 
CaCl2 concentrations of 1.2–1.8 mM that better represent 
the physiological concentrations found in plasma [113]. 
Glucose is often chosen as the only substrate in the buffer 
solution, relying on the ability of the heart to utilize any 
metabolic substrate as a source of energy. This is despite 
the heart normally uses fatty acids as the main energy 
source in vivo [114], which normally account for 64% 
and glucose accounting for 26% of ATP production (the 
remaining percentage is from glycolysis) in the mouse 
heart [115] with similar relative contributions in other 
species. A likely reason for the choice of glucose rather 
than fatty acids is that it is difficult to dissolve the latter 
in aqueous solutions, with the complication that froth-
ing occurs when the solution containing fatty acids is 
gassed [116]. In a solution that contains both calcium and 
phosphate ions, there is a risk of precipitation, forming 
calcium phosphate particles that will block the coronary 
arteries and destroy the heart preparation. Thus, the 
perfusate is bubbled with 5% CO2 to lower the pH, before 
adding CaCl2 and KH2PO4 because the increase in acidity 
inhibits their precipitation. The perfusate is also passed 
through a 5 μm filter to remove particles of impurities 
for the same reason. The lack of plasma proteins in the 
Krebs-Henseleit buffer solution results in a lower oncotic 
pressure than that of the blood [117]. This has the disad-
vantage of causing edema, as suggested by the increased 
accumulation of total tissue water [118]. The lack of 
hemoglobin or other oxygen-binding proteins limits the 
oxygen-carrying capacity of the perfusate. Nevertheless, 
bubbling with 95% O2 compensates for this because the 
perfusate would then have a higher partial pressure of 
oxygen that is sufficient for keeping the heart prepara-
tions viable [88].
In addition to crystalloid solutions described earlier, 
colloid solutions and cell-based perfusates have also been 
used [119]. Colloid solutions can limit the myocardial 
edema induced by large changes in osmolarity caused by 
crystalloid solutions [120]. Furthermore, perfusate con-
taining red blood cells and plasma preserve myocardial 
function better compared to perfusates containing either 
red blood cell concentrate or acellular hemoglobin-based 
oxygen carrier in porcine hearts [121]. The most obvious 
disadvantage is the time needed to prepare these solu-
tions and the higher costs of its use. Moreover, traditional 
gassing methods can cause foam formation and physical 
damage to the red blood cells [122].
Conclusions
This article reviewed the different experimental setups 
that can be used for investigating cardiac electrophysi-
ology, with particular considerations of species, perfu-
sion method, and perfusate composition. Both small and 
large animals can be used for experimentation and the 
decision as to which species to use depends upon cost 
and nature of the pathological conditions studied. Both 
Langendorff and working heart methods have proven 
to be an extremely useful system, whose use has led to 
opportunities for translational application and better 
understanding of the mechanisms underlying cardiac 
arrhythmogenesis.
Acknowledgments: GT thanks the Croucher Foundation 
of Hong Kong for its generous support for his clinical 
assistant professorship and project grant, and the  Faculty 
of Medicine, The Chinese University of Hong Kong for 
research funding.
Yeo et al.: Isolated heart models for studying cardiac electrophysiology      197
Author contributions: All the authors have accepted 
responsibility for the entire content of this submitted 
manuscript and approved submission.
Research funding: Croucher Foundation of Hong Kong, 
Clinical Assistant Professorship.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played 
no role in the study design; in the collection, analysis, and 
interpretation of data; in the writing of the report; or in the 
decision to submit the report for publication.
References
1. Hearse DJ, Sutherland FJ. Experimental models for the study 
of cardiovascular function and disease. Pharmacol Res 
2000;41:597–603.
2. Fink M, Noble D. Pharmacodynamic effects in the cardiovascu-
lar system: the modeller's view. Basic Clin Pharmacol Toxicol 
2010;106:243–9.
3. Hu Z, Chen Z, Wang Y, Jiang J, Tse G, Xu W, et al. Effects of granu-
locyte colony-stimulating factor on rabbit carotid and swine 
heart models of chronic obliterative arterial disease. Mol Med 
Rep 2016.
4. Szel T, Koncz I, Antzelevitch C. Cellular mechanisms underlying 
the effects of milrinone and cilostazol to suppress arrhythmo-
genesis associated with Brugada syndrome. Heart Rhythm 
2013;10:1720–7.
5. Palatinus JA, Gourdie RG. Diabetes increases cryoinjury size with 
associated effects on Cx43 gap junction function and phospho-
rylation in the mouse heart. J Diabetes Res 2016;2016:8789617.
6. George SA, Sciuto KJ, Lin J, Salama ME, Keener JP, Gourdie RG, 
et al. Extracellular sodium and potassium levels modulate car-
diac conduction in mice heterozygous null for the Connexin43 
gene. Pflugers Arch 2015;467:2287–97.
7. Veeraraghavan R, Gourdie RG, Poelzing S. Mechanisms of car-
diac conduction: a history of revisions. Am J Physiol Heart Circ 
Physiol 2014;306:H619–27.
8. Gourdie RG, Green CR, Severs NJ, Anderson RH, Thompson RP. 
Evidence for a distinct gap-junctional phenotype in ventricular 
conduction tissues of the developing and mature avian heart. 
Circ Res 1993;72:278–89.
9. Moses Hr, Dorsey ER, Matheson DH, Thier S. Financial anatomy 
of biomedical research. J Am Med Assoc 2005;294:1333–42.
10. Hall BH. The financing of research and development. Oxf Rev 
Econ Policy 2002;18:35–51.
11. Paton W. Man and mouse: animals in medical research. Oxford: 
Oxford University Press, 1984.
12. Tse G, Wong ST, Tse V, Yeo JM. Depolarization vs. repolarization: 
what is the mechanism of ventricular arrhythmogenesis underly-
ing sodium channel haploinsufficiency in mouse hearts? Acta 
Physiol (Oxf) 2016;218:234–5.
13. Tse G, Wong ST, Tse V, Yeo JM. Variability in local action potential 
durations, dispersion of repolarization and wavelength restitu-
tion in aged wild-type and Scn5a+/– mouse hearts modelling 
human Brugada syndrome. J Geriatr Cardiol 2016.
14. Tse G, Wong ST, Tse V, Yeo JM. Determination of action potential 
wavelength restitution in Scn5a+/– mouse hearts modelling 
human Brugada syndrome. J Geriatr Cardiol 2016.
15. Tse G, Li KH, Laxton V, Chan YW, Keung W, Li RA, et al. Electro-
physiological mechanisms of Brugada syndrome: insights from 
pre-clinical and clinical studies. Front Physiol 2016;7:467.
16. Xu A, Huang Y. A Tireless Giant in Vascular Research. J Cardio-
vasc Pharmacol 2016;67:359–60.
17. Tse G, Yan BP, Chan YW, Tian XY, Huang Y. Reactive oxygen spe-
cies, endoplasmic reticulum stress and mitochondrial dysfunc-
tion: the link with cardiac arrhythmogenesis. Front Physiol 
2016;7:313.
18. Zhang H, Liu J, Qu D, Wang L, Luo JY, Lau CW, et al. Inhibition of 
miR-200c restores endothelial function in diabetic mice through 
suppression of COX-2. Diabetes 2016;65:1196–207.
19. Zheng H, Pu SY, Fan XF, Li XS, Zhang Y, Yuan J, et al. Treat-
ment with angiotensin-(1-9) alleviates the cardiomyopathy 
in streptozotocin-induced diabetic rats. Biochem Pharmacol 
2015;95:38–45.
20. Zhang Y, Liu J, Luo JY, Tian XY, Cheang WS, Xu J, et al. Upregula-
tion of angiotensin (1-7)-mediated signaling preserves endothe-
lial function through reducing oxidative stress in diabetes. 
Antioxid Redox Signal 2015;23:880–92.
21. Murugan D, Lau YS, Lau WC, Mustafa MR, Huang Y. Angiotensin 
1-7 protects against angiotensin II-induced endoplasmic reticu-
lum stress and endothelial dysfunction via Mas receptor. PLoS 
One 2015;10:e0145413.
22. Cheang WS, Tian XY, Wong WT, Lau CW, Lee SS, Chen ZY, et al. 
Metformin protects endothelial function in diet-induced obese 
mice by inhibition of endoplasmic reticulum stress through 5' 
adenosine monophosphate-activated protein kinase-peroxi-
some proliferator-activated receptor delta pathway. Arterioscler 
Thromb Vasc Biol 2014;34:830–6.
23. London B. Mouse models of cardiac arrhythmias. In: Saunders 
JH, editor. Cardiac electrophysiology: from cell to bedside, 4th 
ed. Philadelphia, PA, 2004:433–43.
24. London B. Cardiac arrhythmias: from (transgenic) mice to men. 
J Cardiovasc Electrophysiol 2001;12:1089–91.
25. Baker LC, London B, Choi BR, Koren G, Salama G. Enhanced 
dispersion of repolarization and refractoriness in transgenic 
mouse hearts promotes reentrant ventricular tachycardia. Circ 
Res 2000;86:396–407.
26. Wang L, Swirp S, Duff H. Age-dependent response of the electro-
cardiogram to K(+) channel blockers in mice. Am J Physiol Cell 
Physiol 2000;278:C73–80.
27. Nerbonne JM. Molecular basis of functional voltage-gated K+ 
channel diversity in the mammalian myocardium. J Physiol 
2000;525:285–98.
28. Bers DM. Cardiac excitation-contraction coupling. Nature 
2002;415:198–205.
29. Bers DM, Despa S. Na/K-ATPase – an integral player in the 
adrenergic fight-or-flight response. Trends Cardiovasc Med 
2009;19:111–8.
30. Kettlewell S, Burton FL, Smith GL, Workman AJ. Chronic myocar-
dial infarction promotes atrial action potential alternans, afterde-
polarizations, and fibrillation. Cardiovasc Res 2013;99:215–24.
31. Workman AJ, Kane KA, Rankin AC. Rate-dependency of action 
potential duration and refractoriness in isolated myocytes 
from the rabbit AV node and atrium. J Mol Cell Cardiol 
2000;32:1525–37.
198      Yeo et al.: Isolated heart models for studying cardiac electrophysiology
32. Workman AJ, Kane KA, Rankin AC. Ionic basis of a differential 
effect of adenosine on refractoriness in rabbit AV nodal and 
atrial isolated myocytes. Cardiovasc Res 1999;43:974–84.
33. Workman AJ, Marshall GE, Rankin AC, Smith GL, Dempster 
J. Transient outward K+ current reduction prolongs action 
potentials and promotes afterdepolarisations: a dynamic-clamp 
study in human and rabbit cardiac atrial myocytes. J Physiol 
2012;590:4289–305.
34. Hsieh YC, Lin SF, Huang JL, Hung CY, Lin JC, Liao YC, et al. 
Moderate hypothermia (33C) decreases the susceptibility to 
pacing-induced ventricular fibrillation compared with severe 
hypothermia (30C) by attenuating spatially discordant alternans 
in isolated rabbit hearts. Acta Cardiol Sin 2014;30:455–65.
35. Osadchii OE. Impact of hypokalemia on electromechanical 
window, excitation wavelength and repolarization gradients in 
guinea-pig and rabbit hearts. PLoS One 2014;9:e105599.
36. Ng GA, Cobbe SM, Smith GL. Non-uniform prolongation of intra-
cellular Ca2+ transients recorded from the epicardial surface of 
isolated hearts from rabbits with heart failure. Cardiovasc Res 
1998;37:489–502.
37. Chang C-J, Cheng C-C, Chen Y-C, Kao Y-H, Chen S-A, Chen Y-J. Gap 
junction modifiers regulate electrical activities of the sinoatrial 
node and pulmonary vein: therapeutic implications in atrial 
arrhythmogenesis. Int J Cardiol 2016;221:529–36.
38. Osadchii OE. Effects of ventricular pacing protocol on electri-
cal restitution assessments in guinea-pig heart. Exp Physiol 
2012;97:807–21.
39. Osadchii OE. Flecainide attenuates rate adaptation of ven-
tricular repolarization in guinea-pig heart. Scand Cardiovasc J 
2016;50:28–35.
40. Osadchii OE. Impaired epicardial activation-repolarization 
coupling contributes to the proarrhythmic effects of hypokalae-
mia and dofetilide in guinea pig ventricles. Acta Physiol (Oxf) 
2014;211:48–60.
41. Osadchii OE. Flecainide-induced proarrhythmia is attrib-
uted to abnormal changes in repolarization and refractori-
ness in perfused guinea-pig heart. J Cardiovasc Pharmacol 
2012;60:456–66.
42. Osadchii OE. Dofetilide promotes repolarization abnor-
malities in perfused Guinea-pig heart. Cardiovasc Drugs Ther 
2012;26:489–500.
43. Osadchii OE. Quinidine elicits proarrhythmic changes in ven-
tricular repolarization and refractoriness in guinea-pig. Can J 
Physiol Pharmacol 2013;91:306–15.
44. Osadchii OE, Bentzen BH, Olesen SP. Chamber-specific effects 
of hypokalaemia on ventricular arrhythmogenicity in isolated, 
perfused guinea-pig heart. Exp Physiol 2009;94:434–46.
45. Osadchii OE, Olesen SP. Electrophysiological determinants of 
hypokalaemia-induced arrhythmogenicity in the guinea-pig 
heart. Acta Physiol (Oxf) 2009;197:273–87.
46. Brunner M, Peng X, Liu GX, Ren XQ, Ziv O, Choi BR, et al. Mecha-
nisms of cardiac arrhythmias and sudden death in transgenic 
rabbits with long QT syndrome. J Clin Invest 2008;118:2246–59.
47. Hondeghem LM. Disturbances of cardiac wavelength and repo-
larization precede Torsade de Pointes and ventricular fibrillation 
in Langendorff perfused rabbit hearts. Prog Biophys Mol Biol 
2016;121:3–10.
48. Lu HR, Yan G-X, Gallacher DJ. A new biomarker – index of Cardiac 
Electrophysiological Balance (iCEB) – plays an important role 
in drug-induced cardiac arrhythmias: beyond QT-prolongation 
and Torsades de Pointes (TdPs). J Pharmacol Toxicol Methods 
2013;68:250–9.
49. Milberg P, Reinsch N, Osada N, Wasmer K, Monnig G, Stypmann 
J, et al. Verapamil prevents torsade de pointes by reduction of 
transmural dispersion of repolarization and suppression of early 
afterdepolarizations in an intact heart model of LQT3. Basic Res 
Cardiol 2005;100:365–71.
50. Tse G, Ali A, Prasad SK, Vassiliou V, Raphael CE. Atypical case 
of post-partum cardiomyopathy: an overlap syndrome with 
arrhythmogenic right ventricular cardiomyopathy? BJR Case Rep 
2015;1:20150182.
51. Tse G, Ali A, Alpendurada F, Prasad S, Raphael CE, Vassiliou 
V. Tuberculous constrictive pericarditis. Res Cardiovasc Med 
2015;4:e29614.
52. Vassiliou V, Chin C, Perperoglou A, Tse G, Ali A, Raphael C, et al. 
93 ejection fraction by cardiovascular magnetic resonance 
predicts adverse outcomes post aortic valve replacement. Heart 
2014;100:A53–4.
53. Vaillant F, Magat J, Bour P, Naulin J, Benoist D, Loyer V, et al. 
Magnetic resonance-compatible model of isolated working heart 
from large animal for multimodal assessment of cardiac func-
tion, electrophysiology and metabolism. Am J Physiol Heart Circ 
Physiol 2016;310:H1371–80.
54. Elkins RC. Is tissue-engineered heart valve replacement clini-
cally applicable? Curr Cardiol Rep 2003;5:125–8.
55. Rivard AL, Suwan PT, Imaninaini K, Gallegos RP, Bianco RW. 
Development of a sheep model of atrial fibrillation for preclinical 
prosthetic valve testing. J Heart Valve Dis 2007;16:314–23.
56. Gallegos RP, Nockel PJ, Rivard AL, Bianco RW. The current state 
of in-vivo pre-clinical animal models for heart valve evaluation. J 
Heart Valve Dis 2005;14:423–32.
57. Stengl M. Experimental models of spontaneous ventricu-
lar arrhythmias and of sudden cardiac death. Physiol Res 
2010;59:S25–31.
58. Chen Z, Sun B, Tse G, Jiang J, Xu W. Reversibility of both sinus 
node dysfunction and reduced HCN4 mRNA expression level in an 
atrial tachycardia pacing model of tachycardia-bradycardia syn-
drome in rabbit hearts. Int J Clin Exp Pathol 2016;9:8526–8531.
59. Workman AJ, MacKenzie I, Northover BJ. Do KATP channels open 
as a prominent and early feature during ischaemia in the Langen-
dorff-perfused rat heart? Basic Res Cardiol 2000;95:250–60.
60. Workman AJ, MacKenzie I, Northover BJ. A K(ATP) channel 
opener inhibited myocardial reperfusion action potential short-
ening and arrhythmias. Eur J Pharmacol 2001;419:73–83.
61. Hagendorff A, Schumacher B, Kirchhoff S, Luderitz B, Willecke 
K. Conduction disturbances and increased atrial vulnerability in 
Connexin40-deficient mice analyzed by transesophageal stimu-
lation. Circulation 1999;99:1508–15.
62. Sun B, Qi X, Jiang J. Heptanol decreases the incidence of 
ischemia-induced ventricular arrhythmias through altering 
electrophysiological properties and connexin 43 in rat hearts. 
Biomed Rep 2014;2:349–53.
63. Shi S, Liu T, Wang D, Zhang Y, Liang J, Yang B, et al. Activation of 
N-methyl-d-aspartate receptors reduces heart rate variability and 
facilitates atrial fibrillation in rats. Europace 2016 [ahead of print: 
pii: euw086].
64. Cyon E. Über den einfluss der temperaturänderungen auf zahl, 
dauer und stärke der herzschläge. Berichte über die verhandlun-
gen der königlich sächsischen gesellschaft der wissenschaften 
zu Leipzig. Mathematisch-Physische Classe 1866;18:256–306.
Yeo et al.: Isolated heart models for studying cardiac electrophysiology      199
65. Langendorff O. Untersuchungen am überlebenden Säugetierher-
zen. Pflug Archiv 1898;61:291–332.
66. Taegtmeyer H. One hundred years ago: Oscar Langendorff and 
the birth of cardiac metabolism. Can J Cardiol 1995;11:1030–35.
67. Zimmer HG. The isolated perfused heart and its pioneers. News 
Physiol Sci 1998;13:203–10.
68. Skrzypiec-Spring M, Grotthus B, Szelag A, Schulz R. Isolated 
heart perfusion according to Langendorff---still viable in the new 
millennium. J Pharmacol Toxicol Methods 2007;55:113–26.
69. Wiggers CJ. The innervation of the coronary vessels. Am J Physiol 
1909;24:391–405.
70. Broadley KJ. The Langendorff heart preparation—reappraisal of 
its role as a research and teaching model for coronary vasoac-
tive drugs. J Pharmacol Methods 1979;2:143–56.
71. Katz G, Paine WG, Tiller PM. A new method for coronary 
perfusion of the mammalian heart. Arch Int Pharmacodyn 
1939;61:109–12.
72. Broadley KJ. An analysis of the coronary vascular responses to 
catecholamines, using a modified Langendorff heart prepara-
tion. Br J Pharmacol 1970;40:617–29.
73. Choy L, Yeo JM, Tse V, Chan SP, Tse G. Cardiac disease and 
arrhythmogenesis: mechanistic insights from mouse models. Int 
J Cardiol Heart Vasc 2016;12:1–10.
74. Tse G, Tse V, Yeo JM. Ventricular anti-arrhythmic effects of 
heptanol in hypokalaemic, Langendorff-perfused mouse hearts. 
Biomed Rep 2016;4:313–24.
75. Tse G, Lai ET, Lee AP, Yan BP, Wong SH. Electrophysiological 
mechanisms of gastrointestinal arrhythmogenesis: lessons from 
the heart. Front Physiol 2016;7:230.
76. Sutherland FJ, Shattock MJ, Baker KE, Hearse DJ. Mouse isolated 
perfused heart: characteristics and cautions. Clin Exp Pharma-
col Physiol 2003;30:867–78.
77. Liao R, Podesser BK, Lim CC. The continuing evolution of the 
Langendorff and ejecting murine heart: new advances in cardiac 
phenotyping. Am J Physiol Heart Circ Physiol 2012;303:H156–67.
78. Neely JR, Rovetto MJ, Whitmer JT, Morgan HE. Effects of ischemia 
on function and metabolism of the isolated working rat heart. 
Am J Physiol 1973;225:651–8.
79. Neely JR, Liebermeister H, Battersby EJ, Morgan HE. Effect of 
pressure development on oxygen consumption by isolated rat 
heart. Am J Physiol 1967;212:804–14.
80. Bateman MG, Iaizzo PA. Comparative imaging of cardiac 
structures and function for the optimization of transcatheter 
approaches for valvular and structural heart disease. Int J Car-
diovasc Imaging 2011;27:1223–34.
81. Chinchoy E, Soule CL, Houlton AJ, Gallagher WJ, Hjelle MA, Laske 
TG, et al. Isolated four-chamber working swine heart model. Ann 
Thorac Surg 2000;70:1607–14.
82. Martin HN, Applegrath EC. On the temperature limits of the vital-
ity of the mammalian heart. Stud Biol Lab Johns Hopkins Univ 
1890;4:275.
83. Manuck HP, Hockman CH. Central nervous system mechanisms 
mediating cardiac rate and rhythm. Am Heart J 1967;74:96–109.
84. Gellhorn E. The significance of the state of the central autonomic 
nervous system for quantitative and qualitative aspects of some 
cardiovascular reactions. Am Heart J 1963;67:106–20.
85. Mason DT. The autonomic nervous system and regulation of 
cardiovascular performance. Anesthesiology 1968;29:670–80.
86. Wolf S. Neural mechanisms in sudden cardiac death. Trans Am 
Clin Climatol Assoc 1968;79:158–76.
87. Coumel P. Cardiac arrhythmias and the autonomic nervous 
system. J Cardiovasc Electrophysiol 1993;4:338–55.
88. Sutherland FJ, Hearse DJ. The isolated blood and perfusion 
fluid perfused heart. Pharmacol Res 2000;41:613–27.
89. Mantravadi R, Gabris B, Liu T, Choi BR, de Groat WC, Ng GA, 
et al. Autonomic nerve stimulation reverses ventricular  repo-
larization sequence in rabbit hearts. Circ Res 2007;100:e72–80.
90. Ng GA, Brack KE, Coote JH. Effects of direct sympathetic and 
vagus nerve stimulation on the physiology of the whole heart--a 
novel model of isolated Langendorff perfused rabbit heart with 
intact dual autonomic innervation. Exp Physiol 2001;86:319–29.
91. Brack KE, Coote JH, Ng GA. Interaction between direct sympa-
thetic and vagus nerve stimulation on heart rate in the isolated 
rabbit heart. Exp Physiol 2004;89:128–39.
92. Brack KE, Coote JH, Ng GA. The effect of direct autonomic 
nerve stimulation on left ventricular force in the isolated 
innervated Langendorff perfused rabbit heart. Auton Neurosci 
2006;124:69–80.
93. Brack KE, Coote JH, Ng GA. Vagus nerve stimulation inhibits 
the increase in Ca2+ transient and left ventricular force caused 
by sympathetic nerve stimulation but has no direct effects 
alone--epicardial Ca2+ fluorescence studies using fura-2 AM 
in the isolated innervated beating rabbit heart. Exp Physiol 
2010;95:80–92.
94. Ng GA, Brack KE, Patel VH, Coote JH. Autonomic modulation of 
electrical restitution, alternans and ventricular fibrillation ini-
tiation in the isolated heart. Cardiovasc Res 2007;73:750–60.
95. Brack KE, Patel VH, Coote JH, Ng GA. Nitric oxide mediates the 
vagal protective effect on ventricular fibrillation via effects 
on action potential duration restitution in the rabbit heart. 
J Physiol 2007;583:695–704.
96. Ng GA, Mantravadi R, Walker WH, Ortin WG, Choi BR, de Groat 
W, et al. Sympathetic nerve stimulation produces spatial 
heterogeneities of action potential restitution. Heart Rhythm 
2009;6:696–706.
97. Winter J, Brack KE, Coote JH, Ng GA. Cardiac contractility 
modulation increases action potential duration dispersion and 
decreases ventricular fibrillation threshold via beta1-adreno-
ceptor activation in the crystalloid perfused normal rabbit 
heart. Int J Cardiol 2014;172:144–54.
98. Ng GA. Vagal modulation of cardiac ventricular arrhythmia. Exp 
Physiol 2014;99:295–9.
99. Valentin JP, Hoffmann P, De Clerck F, Hammond TG, Hondeghem 
L. Review of the predictive value of the Langendorff heart 
model (Screenit system) in assessing the proarrhythmic poten-
tial of drugs. J Pharmacol Toxicol Methods 2004;49:171–81.
100. Tse G, Yeo JM, Tse V, Sun B. Gap junction inhibition by heptanol 
increases ventricular arrhythmogenicity by decreasing conduc-
tion velocity without affecting repolarization properties or myo-
cardial refractoriness in Langendorff-perfused mouse hearts. 
Mol Med Rep 2016;14:4069–4074.
101. Tse G, Lai ET, Chan YW, Yeo JM, Yan BP. What is the arrhythmic 
substrate in viral myocarditis? Insights from clinical and animal 
studies. Front Physiol 2016;7:308.
102. Tse G, Lai ET, Yeo JM, Yan BP. Electrophysiological mechanisms 
of Bayés syndrome: insights from clinical and mouse studies. 
Front Physiol 2016;7:188.
103. Tse G, Lai ET, Tse V, Yeo JM. Molecular and electrophysiological 
mechanisms underlying cardiac arrhythmogenesis in diabetes 
mellitus. J Diabetes Res 2016:2848759.
200      Yeo et al.: Isolated heart models for studying cardiac electrophysiology
104. Pye MP, Cobbe SM. Arrhythmogenesis in experimental models 
of heart failure: the role of increased load. Cardiovasc Res 
1996;32:248–57.
105. Nicolson WB, McCann GP, Brown PD, Sandilands AJ, Stafford PJ, 
Schlindwein FS, et al. A novel surface electrocardiogram-based 
marker of ventricular arrhythmia risk in patients with ischemic 
cardiomyopathy. J Am Heart Assoc 2012;1:e001552.
106. Nicolson WB, McCann GP, Smith MI, Sandilands AJ, Stafford 
PJ, Schlindwein FS, et al. Prospective evaluation of two novel 
ECG-based restitution biomarkers for prediction of sud-
den cardiac death risk in ischaemic cardiomyopathy. Heart 
2014;100:1878–85.
107. Tse G. Both transmural dispersion of repolarization and 
transmural dispersion of refractoriness are poor predictors of 
arrhythmogenicity: a role for the index of Cardiac Electrophysi-
ological Balance (QT/QRS)? J Geriatr Cardiol 2016;13:813–4.
108. Tse G. (Tpeak-Tend)/QRS and (Tpeak-Tend)/(QT x QRS): novel 
markers for predicting arrhythmic risk in the Brugada syn-
drome. Europace 2016; pii: euw194.
109. Tse G, Yan BP. Traditional and novel electrocardiographic con-
duction and repolarization markers of sudden cardiac death. 
Europace 2016; pii: euw280.
110. Tse G. Novel conduction-repolarization indices for the stratifi-
cation of arrhythmic risk. J Geriatr Cardiol 2016;13:811–812.
111. Curtis MJ, Hancox JC, Farkas A, Wainwright CL, Stables CL, Saint 
DA, et al. The Lambeth Conventions (II): Guidelines for the 
study of animal and human ventricular and supraventricular 
arrhythmias. Pharmacol Ther 2013;139:213–48.
112. Krebs HA, Henseleit K. Untersuchungen ueber die Harnst-
offbildung im Tierkoerper. Hoppe-Seyler's Z Physiol Chem 
1932;210:33–6.
113. Reichelt ME, Willems L, Hack BA, Peart JN, Headrick JP. Cardiac 
and coronary function in the Langendorff-perfused mouse 
heart model. Exp Physiol 2009;94:54–70.
114. Bing RJ, Siegel A, Ungar I, Gilbert M. Studies on fat, ketone and 
amino acid metabolism. Am J Med 1954;16:504–15.
115. Belke DD, Larsen TS, Lopaschuk GD, Severson DL. Glucose and 
fatty acid metabolism in the isolated working mouse heart. Am 
J Physiol 1999;277:R1210–7.
116. Bell RM, Mocanu MM, Yellon DM. Retrograde heart perfusion: 
the Langendorff technique of isolated heart perfusion. J Mol 
Cell Cardiol 2011;50:940–50.
117. Bing RJ. Some aspects of biochemistry of myocardial infarction. 
Cell Mol Life Sci 2001;58:351–5.
118. Qiu Y, Hearse DJ. Comparison of ischemic vulnerability and 
responsiveness to cardioplegic protection in crystalloid-per-
fused versus blood-perfused hearts. J Thorac Cardiovasc Surg 
1992;103:960–8.
119. Armitage WJ, Pegg DE. An evaluation of colloidal solutions for 
normothermic perfusion of rabbit hearts: an improved perfu-
sate containing Haemaccel. Cryobiology 1977;14:428–34.
120. Zausig YA, Chappell D, Becker BF, Potschka D, Busse H, Nixdorf 
K, et al. The impact of crystalloidal and colloidal infusion prep-
arations on coronary vascular integrity, interstitial oedema and 
cardiac performance in isolated hearts. Crit Care 2013;17:R203.
121. White CW, Hasanally D, Mundt P, Li Y, Xiang B, Klein J, et al. A 
whole blood-based perfusate provides superior preservation 
of myocardial function during ex vivo heart perfusion. J Heart 
Lung Transplant 2015;34:113–21.
122. Pasini E, Solfrini R, Bachetti T, Marino M, Bernocchi P, Visioli F, 
et al. The blood perfused isolated heart: characterization of the 
model. Basic Res Cardiol 1999;94:215–22.
Reproduced with permission of copyright owner.
Further reproduction prohibited without permission.
